MAIA — MAIA Biotechnology Inc.
NYSE MKT · Healthcare · Biotechnology
$1.37
+$0.07 (+5.43%)
MAIA Biotechnology Inc. (MAIA) is a biotechnology company listed on NYSE MKT. It is led by Vlad Vitoc M.B.A., M.D., based in 444 West Lake Street, Chicago, IL, United States, 60606, with about 13 employees. MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Net income was -$8.9M. MAIA currently screens at market cap $56.9M.
Use this MAIA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MAIA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MAIA SEC filings page. Lician reads the product cache first so this HTML stays unique to MAIA Biotechnology Inc. even when a live quote feed is slow.
About MAIA Biotechnology Inc.
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
MAIA Key Statistics
Market Cap
$56.93M
Volume
914,292
Previous Close
$1.35
Day Range
$1.36 – $1.46
EPS
-$1.05
Revenue
$0.00
Net Income
-$23.25M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
13
MAIA Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$23.25M | -$19.77M | -$15.77M | -$12.58M |
| EPS (Diluted) | -$1.05 | -$1.49 | -$1.75 | -$2.37 |
Total Assets
$10.16M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$0.00
Operating Cash Flow
-$15.70M
Free Cash Flow
$0.00
MAIA Biotechnology Inc. Company Information
- Co-Founder, President, CEO & Chairman of the Board of Directors
- Vlad Vitoc M.B.A., M.D.
- Headquarters
- 444 West Lake Street, Chicago, IL, United States, 60606
- Website
- maiabiotech.com
- Phone
- 312-416-8592
- IPO / Founded
- 2022-07-28
- Sector
- Healthcare
- Industry
- Biotechnology